Sio Capital Management
Latest statistics and disclosures from Sio Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Quotient Ltd shs, JNJ, SNY, ISRG, AET, and represent 24.65% of Sio Capital Management's stock portfolio.
- Added to shares of these 10 stocks: ISRG (+$8.61M), HCA HOLDINGS Inc (+$7.89M), Allergan (+$7.29M), LPNT (+$6.71M), JNJ (+$5.29M), SGEN (+$5.17M), Abbvie (+$5.08M), Agios Pharmaceuticals, Halyard Health, PKI.
- Started 26 new stock positions in Anthem, Allergan, Halyard Health, ACAD, HCA HOLDINGS Inc, Axovant Sciences, Catalyst Biosciences, SGEN, BABY, Zynerba Pharmaceuticals.
- Reduced shares in these 10 stocks: ACOR (-$13.11M), , Puma Biotechnology Inc Common Stock (-$7.00M), GSK (-$6.40M), , , SNY, Adamis Pharmaceuticals Corp Com Stk, PFE, Sage Therapeutics.
- Sold out of its positions in ALNY, Anthera Pharmaceutcls, BIIB, Biopharmx, BSX, CAH, CERN, Coherus Biosciences, Forward Pharma A/s, Inotek Pharmaceuticals. MRK, MOH, Newlink Genetics Corporation, PFE, Quintiles Transnatio Hldgs I, TEVA, VRTX.
- Sio Capital Management was a net buyer of stock by $18.29M.
- Sio Capital Management has $210.44M in assets under management (AUM), growing by 17.71%.
Companies in the Sio Capital Management portfolio as of June 2017 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Change in Shares | Price |
|---|---|---|---|---|
| Quotient Ltd shs | 8.27 | 2.37M | 7.36 | |
| Johnson & Johnson (JNJ) | 4.40 | 70000 | +133% | 132.29 |
| Sanofi-Aventis SA (SNY) | 4.13 | 181622 | -32% | 47.91 |
| Intuitive Surgical (ISRG) | 4.09 | 9200 | NEW | 935.33 |
| Aetna (AET) | 3.75 | 52000 | +40% | 151.83 |
| HCA HOLDINGS Inc | 3.75 | 90420 | NEW | 87.21 |
| Acorda Therapeutics (ACOR) | 3.56 | 380000 | -63% | 19.70 |
| Koninklijke Philips Electronics NV (PHG) | 3.48 | 204486 | -16% | 35.82 |
| Allergan | 3.47 | 30000 | NEW | 243.10 |
| Puma Biotechnology Inc Common Stock | 3.32 | 80021 | -50% | 87.40 |
| LifePoint Hospitals (LPNT) | 3.19 | 100000 | NEW | 67.15 |
| Thermo Fisher Scientific (TMO) | 2.98 | 35965 | +19% | 174.48 |
| Eli Lilly & Co. (LLY) | 2.87 | 73473 | +27% | 82.31 |
| Seattle Genetics (SGEN) | 2.46 | 100000 | NEW | 51.74 |
| Abbvie | 2.41 | 70000 | NEW | 72.51 |
| GlaxoSmithKline (GSK) | 2.32 | 113113 | -56% | 43.12 |
| Sage Therapeutics | 2.27 | 60000 | -41% | 79.63 |
| Tabula Rasa Healthcare | 2.24 | 312630 | -24% | 15.05 |
| Insmed Inc | 2.17 | 266600 | +213% | 17.16 |
| Agios Pharmaceuticals | 2.03 | 83100 | NEW | 51.44 |
| Advanced Accelerat spon ads each rep 2 ord shs | 2.01 | 108523 | 39.04 | |
| Halyard Health | 1.88 | 100599 | NEW | 39.28 |
| UnitedHealth (UNH) | 1.86 | 21151 | 185.43 | |
| Globus Med Inc cl a | 1.79 | 113400 | +89% | 33.15 |
| PerkinElmer (PKI) | 1.75 | 53899 | NEW | 68.15 |
| Rigel Pharmaceuticals (RIGL) | 1.75 | 1.35M | -28% | 2.73 |
| Regeneron Pharmaceuticals (REGN) | 1.63 | 7000 | NEW | 491.14 |
| Smith & Nephew (SNN) | 1.28 | 77244 | 34.85 | |
| Medtronic | 1.27 | 30000 | 88.77 | |
| Anthem | 1.23 | 13767 | NEW | 188.13 |
| Mazor Robotics Ltd. equities | 1.22 | 73948 | +135% | 34.58 |
| Natus Medical (BABY) | 1.21 | 68095 | NEW | 37.30 |
| Nevro | 1.18 | 33250 | NEW | 74.44 |
| Luminex Corporation (LMNX) | 1.16 | 115979 | NEW | 21.12 |
| Endologix (ELGX) | 1.14 | 493060 | NEW | 4.86 |
| Chemocentryx | 1.09 | 244850 | -16% | 9.36 |
| Viewray | 0.97 | 313947 | NEW | 6.47 |
| Penumbra | 0.83 | 20000 | NEW | 87.75 |
| ACADIA Pharmaceuticals (ACAD) | 0.79 | 60000 | NEW | 27.88 |
| Catalyst Biosciences | 0.78 | 353172 | NEW | 4.65 |
| Medifast (MED) | 0.76 | 38500 | NEW | 41.48 |
| Vocera Communications | 0.70 | 56106 | +12% | 26.41 |
| Zynerba Pharmaceuticals | 0.57 | 70300 | NEW | 16.97 |
| Clovis Oncology | 0.56 | 12500 | NEW | 93.60 |
| Arena Pharmaceuticals | 0.56 | 69352 | NEW | 16.87 |
| Steadymed Ltd shs | 0.50 | 168000 | NEW | 6.30 |
| Flamel Technologies Sa | 0.48 | 91413 | 11.03 | |
| Axsome Therapeutics | 0.42 | 160000 | -23% | 5.50 |
| Axovant Sciences | 0.33 | 29700 | NEW | 23.20 |
| Foamix Pharmaceuticals Ltd shs | 0.31 | 139200 | NEW | 4.64 |
| Adamis Pharmaceuticals Corp Com Stk | 0.30 | 122506 | -86% | 5.20 |
| Aeglea Biotherapeutics | 0.24 | 129583 | -23% | 3.85 |
| Pfenex | 0.16 | 85867 | 4.01 | |
| Oasmia Pharmaceutical Ab | 0.10 | 203170 | +2% | 1.05 |
| Sunesis Pharmaceuticals Inc Ne | 0.04 | 33710 | -89% | 2.70 |
Download CSV 
Past 13F-HR SEC Filings by Sio Capital Management
- Sio Capital Management 2017 Q1 filed May 15, 2017
- Sio Capital Management 2016 Q4 filed Feb. 14, 2017
- Sio Capital Management 2016 Q3 filed Nov. 15, 2016
- Sio Capital Management 2016 Q2 filed Aug. 15, 2016
- Sio Capital Management 2016 Q1 filed May 16, 2016
- Sio Capital Management 2015 Q4 filed Feb. 16, 2016
- Sio Capital Management 2015 Q3 filed Nov. 13, 2015
- Sio Capital Management 2015 Q1 filed May 15, 2015
- Sio Capital Management 2014 Q4 filed Feb. 17, 2015
- Sio Capital Management 2011 Q1 filed May 17, 2011
- Sio Capital Management 2010 Q4 filed Feb. 8, 2011